Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,667 | 170 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $821.51 | 28 | $0 (2024) |
| Novo Nordisk Inc | $422.42 | 15 | $0 (2024) |
| Lilly USA, LLC | $369.86 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $335.02 | 20 | $0 (2024) |
| PFIZER INC. | $264.46 | 18 | $0 (2024) |
| Abbott Laboratories | $237.85 | 14 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $157.57 | 6 | $0 (2020) |
| ABBVIE INC. | $141.91 | 10 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $137.69 | 2 | $0 (2021) |
| Esperion Therapeutics, Inc. | $98.07 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $854.21 | 46 | Novo Nordisk Inc ($203.70) |
| 2023 | $548.55 | 31 | Abbott Laboratories ($106.41) |
| 2022 | $460.07 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($135.46) |
| 2021 | $753.67 | 26 | AstraZeneca Pharmaceuticals LP ($229.64) |
| 2020 | $373.46 | 11 | AstraZeneca Pharmaceuticals LP ($262.79) |
| 2019 | $123.61 | 7 | Coloplast Corp ($31.93) |
| 2018 | $80.75 | 6 | ARBOR PHARMACEUTICALS, INC. ($32.04) |
| 2017 | $472.60 | 15 | AstraZeneca Pharmaceuticals LP ($137.57) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $38.55 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Obesity | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: PAIN | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Obesity | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $109.01 | General |
| Category: Obesity | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: PAIN | ||||||
| 10/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: VACCINES | ||||||
| 09/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: PAIN | ||||||
| 09/11/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes Care | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Obesity | ||||||
| 08/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: PAIN | ||||||
| 07/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes Care | ||||||
| 07/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: PAIN | ||||||
| 06/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 582 | 837 | $63,019 | $32,129 |
| 2022 | 13 | 443 | 652 | $52,837 | $26,954 |
| 2021 | 12 | 468 | 654 | $52,041 | $27,454 |
| 2020 | 11 | 410 | 605 | $46,146 | $20,555 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 172 | $29,240 | $14,881 | 50.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $6,235 | $5,314 | 85.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 34 | $7,480 | $3,990 | 53.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 20 | $1,950 | $1,428 | 73.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 19 | $2,375 | $1,171 | 49.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 75 | 121 | $2,239 | $1,016 | 45.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 44 | 44 | $2,200 | $773.96 | 35.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 41 | 41 | $1,025 | $721.19 | 70.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 20 | $870.00 | $590.20 | 67.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 16 | $1,680 | $553.92 | 33.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 49 | 68 | $1,360 | $415.48 | 30.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 36 | $1,620 | $355.41 | 21.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 34 | $1,870 | $351.36 | 18.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 49 | 68 | $1,360 | $345.44 | 25.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 66 | 101 | $1,515 | $222.20 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 178 | $30,260 | $14,845 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $5,075 | $4,432 | 87.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 28 | $6,160 | $3,543 | 57.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,365 | $959.56 | 70.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 12 | $1,080 | $517.00 | 47.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 28 | 28 | $700.00 | $498.24 | 71.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 25 | 25 | $1,250 | $452.91 | 36.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $609.00 | $397.32 | 65.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 43 | 60 | $1,200 | $369.66 | 30.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 43 | 60 | $1,200 | $307.35 | 25.6% |
About Dr. Manju Pandey, MD
Dr. Manju Pandey, MD is a Family Medicine healthcare provider based in Prosper, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1396070348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manju Pandey, MD has received a total of $3,667 in payments from pharmaceutical and medical device companies, with $854.21 received in 2024. These payments were reported across 170 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,667).
As a Medicare-enrolled provider, Pandey has provided services to 1,903 Medicare beneficiaries, totaling 2,748 services with total Medicare billing of $107,094. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Prosper, TX
- Active Since 10/08/2009
- Last Updated 08/14/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396070348
Products in Payments
- JARDIANCE (Drug) $411.67
- FARXIGA (Drug) $387.69
- Wegovy (Drug) $240.93
- NURTEC ODT (Drug) $235.95
- BREZTRI (Drug) $233.13
- FREESTYLE LIBRE 3 (Device) $190.80
- Kerendia (Drug) $137.69
- MOUNJARO (Drug) $117.40
- BEVESPI AEROSPHERE (Drug) $113.58
- EMGALITY (Drug) $106.61
- BELSOMRA (Drug) $104.37
- Victoza (Drug) $100.00
- NEXLIZET (Drug) $98.07
- QULIPTA (Drug) $86.81
- QSYMIA (Drug) $83.55
- TRULICITY (Drug) $69.20
- Saxenda (Drug) $55.87
- Edarbi (Drug) $51.66
- JANUVIA (Drug) $44.54
- TRINTELLIX (Drug) $43.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Prosper
Dr. Matthew Nguyen, Md, MD
Family Medicine — Payments: $4,016
Dr. Stanly Heckrodt, Md, D.ph, MD, D.PH
Family Medicine — Payments: $3,687
William Dodge, M.d, M.D
Family Medicine — Payments: $2,637
Dr. Amit Mulchandani, Md, MD
Family Medicine — Payments: $2,504
Karna Gocke, M.d, M.D
Family Medicine — Payments: $1,560
Dr. Jonathan Thomas, M.d, M.D
Family Medicine — Payments: $1,365